AKL-T01 may provide additional treatment benefit to children with attention-deficit/hyperactivity disorder (ADHD).
Why this matters ?
ADHD is a commonly diagnosed pediatric mental health disorder. Current front-line therapies have demonstrated short-term efficacy and have many limitations. Thus, additional approaches to augment multimodal ADHD management is needed.
Digital therapeutics may provide improved access, minimal side effects and a low potential for abuse.